These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database. Cano EL; Haque NZ; Welch VL; Cely CM; Peyrani P; Scerpella EG; Ford KD; Zervos MJ; Ramirez JA; Kett DH; Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995 [TBL] [Abstract][Full Text] [Related]
7. Risk of nephrotoxicity with combination vancomycin-aminoglycoside antibiotic therapy. Pauly DJ; Musa DM; Lestico MR; Lindstrom MJ; Hetsko CM Pharmacotherapy; 1990; 10(6):378-82. PubMed ID: 2287556 [TBL] [Abstract][Full Text] [Related]
8. A comparative assessment of vancomycin-associated nephrotoxicity in the young versus the elderly hospitalized patient. Vance-Bryan K; Rotschafer JC; Gilliland SS; Rodvold KA; Fitzgerald CM; Guay DR J Antimicrob Chemother; 1994 Apr; 33(4):811-21. PubMed ID: 8056700 [TBL] [Abstract][Full Text] [Related]
10. Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy. Cimino MA; Rotstein C; Slaughter RL; Emrich LJ Am J Med; 1987 Dec; 83(6):1091-7. PubMed ID: 3503577 [TBL] [Abstract][Full Text] [Related]
11. Outcomes and Nephrotoxicity Associated with Vancomycin Treatment in Patients 80 Years and Older. Wang Y; Dai N; Wei W; Jiang C Clin Interv Aging; 2021; 16():1023-1035. PubMed ID: 34103905 [TBL] [Abstract][Full Text] [Related]
12. Nephrotoxicity induced by gentamicin and amikacin. Smith CR; Maxwell RR; Edwards CQ; Rogers JF; Lietman PS Johns Hopkins Med J; 1978 Mar; 142(3):85-90. PubMed ID: 342789 [TBL] [Abstract][Full Text] [Related]
13. A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function. Sweileh WM Fundam Clin Pharmacol; 2009 Aug; 23(4):515-20. PubMed ID: 19709328 [TBL] [Abstract][Full Text] [Related]
14. Impact of aminoglycoside serum assays on clinical decisions and renal toxicity. Arroyo JC; Milligan WL; Davis J; Mitchell D South Med J; 1986 Mar; 79(3):272-6. PubMed ID: 3513326 [TBL] [Abstract][Full Text] [Related]
15. Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients. Chuma M; Makishima M; Imai T; Tochikura N; Suzuki S; Kuwana T; Sawada N; Komatsu T; Sakaue T; Kikuchi N; Yoshida Y; Kinoshita K Ther Drug Monit; 2018 Feb; 40(1):109-114. PubMed ID: 29095798 [TBL] [Abstract][Full Text] [Related]
16. Relationship between vancomycin-associated nephrotoxicity and the number of combined nephrotoxic agents. Ueki T; Sanematsu E; Furuya Y; Shinohara Y; Murakami Y; Miyazaki A; Sakamoto Y; Nakashima MN; Nakashima M Pharmazie; 2020 Jun; 75(6):279-283. PubMed ID: 32539926 [TBL] [Abstract][Full Text] [Related]
17. Incidence and predictors of vancomycin-associated nephrotoxicity. Moh'd H; Kheir F; Kong L; Du P; Farag H; Mohamad A; Zurlo JJ South Med J; 2014 Jun; 107(6):383-8. PubMed ID: 24945176 [TBL] [Abstract][Full Text] [Related]
19. Evaluating Renal Stress Using Pharmacokinetic Urinary Biomarker Data in Critically Ill Patients Receiving Vancomycin and/or Piperacillin-Tazobactam: A Secondary Analysis of the Multicenter Sapphire Study. Kane-Gill SL; Ostermann M; Shi J; Joyce EL; Kellum JA Drug Saf; 2019 Oct; 42(10):1149-1155. PubMed ID: 31240688 [TBL] [Abstract][Full Text] [Related]
20. Nephrotoxicity of aminoglycosides, polypeptides and cephalosporins in cancer patients. Krcméry V; Fuchsberger P; Gocár M; Salát T; Bodnárová J; Sobota R; Koza I; Svec J Chemotherapy; 1991; 37(4):287-91. PubMed ID: 1790727 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]